long term side effects of glp-1 receptor agonists Your guide to GLP-1 and GIP-1 receptor agonists

Some researchers have moved their eyes to small-molecule GLP-1RA - with high oral bioavailability, and high patient compliance

Far along in research and development is Eli Lillys retatrutide, a triple agonist that adds glucagon to GLP-1 and GIP, and the requisite studies are underway.1,14 In addition, theres cagrisema from NovoNordisk, a blend of semaglutide (GLP-1 agonist) and a long-acting amylin (another pancreatic hormone) analog cargrilintide

Heiss, C

[DOI] [PMC free article] [PubMed] [Google Scholar] 98.Gerstein H.C., Colhoun H.M., Dagenais G.R., Diaz R., Lakshmanan M., Pais P

Combined with your metabolic profile, these insights guide whether semaglutide, tirzepatide, or a dual compound offers the strongest personalized response